{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ALIMENTARY TRACT AND METABOLISM" , "@language" : "en" } ,        { "@value" : "Tr\u00E1vic\u00ED trakt a metabolismus" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/A10",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "L\u00E9\u010Diva k terapii diabetu" , "@language" : "cs" } ,        { "@value" : "DRUGS USED IN DIABETES" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "A10" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/A10B",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Antidiabetika, krom\u011B inzulin\u016F" , "@language" : "cs" } ,        { "@value" : "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "A10B" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/A10BX",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Jin\u00E1 antidiabetika, krom\u011B inzulin\u016F" , "@language" : "cs" } ,        { "@value" : "Other blood glucose lowering drugs, excl. insulins" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "A10BX" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/A10BX02",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/A10BX" ,        "http://linked.opendata.cz/resource/ATC/A10B" ,        "http://linked.opendata.cz/resource/ATC/A10" ,        "http://linked.opendata.cz/resource/ATC/A" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Repaglinid" , "@language" : "cs" } ,        { "@value" : "Repaglinide" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "A10BX02" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000952",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Diabetes mellitus 1. typu" , "@language" : "cs" } ,        { "@value" : "Diabetes mellitus, type 1" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000003499",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Diabetic ketoacidosis" , "@language" : "en" } ,        { "@value" : "Diabetick\u00E1 ketoacid\u00F3za" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0196126",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Repaglinide" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000952" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003499" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/ADEREGL-0-5-MG-TABLETY",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0196126" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ADEREGL 0,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A10BX02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0165003" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0165005" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0165002" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162000" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0165004" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0165001" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0165001",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ADEREGL 0,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A10BX02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIDIABETICA (V\u010CETN\u011A INSULINU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132178_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "90" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu (non-inzulin-dependentn\u00ED diabetes mellitus: NIDDM), u nich\u017E dieta, redukce hmotnosti a cvi\u010Den\u00ED nesta\u010D\u00ED k \u00FAprav\u011B hladin krevn\u00EDho cukru. Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu tak\u00E9 v kombinaci s metforminem, pokud samotn\u00FD metformin hladinu krevn\u00EDho cukru dostate\u010Dn\u011B neupravil. \nL\u00E9\u010Dbu zahajujeme jako dopln\u011Bk diety a cvi\u010Den\u00ED, aby bylo dosa\u017Eeno sn\u00ED\u017Een\u00ED hladin krevn\u00EDho cukru v z\u00E1vislosti na j\u00EDdle. \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 90X0.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0165005",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ADEREGL 0,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A10BX02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIDIABETICA (V\u010CETN\u011A INSULINU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132178_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "270" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu (non-inzulin-dependentn\u00ED diabetes mellitus: NIDDM), u nich\u017E dieta, redukce hmotnosti a cvi\u010Den\u00ED nesta\u010D\u00ED k \u00FAprav\u011B hladin krevn\u00EDho cukru. Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu tak\u00E9 v kombinaci s metforminem, pokud samotn\u00FD metformin hladinu krevn\u00EDho cukru dostate\u010Dn\u011B neupravil. \nL\u00E9\u010Dbu zahajujeme jako dopln\u011Bk diety a cvi\u010Den\u00ED, aby bylo dosa\u017Eeno sn\u00ED\u017Een\u00ED hladin krevn\u00EDho cukru v z\u00E1vislosti na j\u00EDdle. \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 270X0.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0165002",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ADEREGL 0,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A10BX02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIDIABETICA (V\u010CETN\u011A INSULINU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132178_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "120" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu (non-inzulin-dependentn\u00ED diabetes mellitus: NIDDM), u nich\u017E dieta, redukce hmotnosti a cvi\u010Den\u00ED nesta\u010D\u00ED k \u00FAprav\u011B hladin krevn\u00EDho cukru. Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu tak\u00E9 v kombinaci s metforminem, pokud samotn\u00FD metformin hladinu krevn\u00EDho cukru dostate\u010Dn\u011B neupravil. \nL\u00E9\u010Dbu zahajujeme jako dopln\u011Bk diety a cvi\u010Den\u00ED, aby bylo dosa\u017Eeno sn\u00ED\u017Een\u00ED hladin krevn\u00EDho cukru v z\u00E1vislosti na j\u00EDdle. \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 120X0.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162000",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ADEREGL 0,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A10BX02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIDIABETICA (V\u010CETN\u011A INSULINU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132178_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu (non-inzulin-dependentn\u00ED diabetes mellitus: NIDDM), u nich\u017E dieta, redukce hmotnosti a cvi\u010Den\u00ED nesta\u010D\u00ED k \u00FAprav\u011B hladin krevn\u00EDho cukru. Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu tak\u00E9 v kombinaci s metforminem, pokud samotn\u00FD metformin hladinu krevn\u00EDho cukru dostate\u010Dn\u011B neupravil. \nL\u00E9\u010Dbu zahajujeme jako dopln\u011Bk diety a cvi\u010Den\u00ED, aby bylo dosa\u017Eeno sn\u00ED\u017Een\u00ED hladin krevn\u00EDho cukru v z\u00E1vislosti na j\u00EDdle. \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 30X0.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0165004",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ADEREGL 0,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A10BX02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIDIABETICA (V\u010CETN\u011A INSULINU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132178_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "90" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu (non-inzulin-dependentn\u00ED diabetes mellitus: NIDDM), u nich\u017E dieta, redukce hmotnosti a cvi\u010Den\u00ED nesta\u010D\u00ED k \u00FAprav\u011B hladin krevn\u00EDho cukru. Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu tak\u00E9 v kombinaci s metforminem, pokud samotn\u00FD metformin hladinu krevn\u00EDho cukru dostate\u010Dn\u011B neupravil. \nL\u00E9\u010Dbu zahajujeme jako dopln\u011Bk diety a cvi\u010Den\u00ED, aby bylo dosa\u017Eeno sn\u00ED\u017Een\u00ED hladin krevn\u00EDho cukru v z\u00E1vislosti na j\u00EDdle. \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 90X0.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0165003",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ADEREGL 0,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A10BX02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIDIABETICA (V\u010CETN\u011A INSULINU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132178_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "270" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu (non-inzulin-dependentn\u00ED diabetes mellitus: NIDDM), u nich\u017E dieta, redukce hmotnosti a cvi\u010Den\u00ED nesta\u010D\u00ED k \u00FAprav\u011B hladin krevn\u00EDho cukru. Repaglinid je indikov\u00E1n u pacient\u016F s diabetem 2. typu tak\u00E9 v kombinaci s metforminem, pokud samotn\u00FD metformin hladinu krevn\u00EDho cukru dostate\u010Dn\u011B neupravil. \nL\u00E9\u010Dbu zahajujeme jako dopln\u011Bk diety a cvi\u010Den\u00ED, aby bylo dosa\u017Eeno sn\u00ED\u017Een\u00ED hladin krevn\u00EDho cukru v z\u00E1vislosti na j\u00EDdle. \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 270X0.5MG" , "@language" : "cs" } ] }] }